Crossmark

A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHD

Crossref DOI link: https://doi.org/10.1038/s41375-018-0183-0

Published Online: 2018-06-27

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sauer, Sandra

Hüsing, Johannes

Hajda, Jacek

Neumann, Frank

Radujkovic, Aleksandar

Ho, Anthony D.

Dreger, Peter

Luft, Thomas
License Information

Text and Data Mining valid from 2018-06-27
More Information

Article History

Received: 21 February 2018

Revised: 22 May 2018

Accepted: 30 May 2018

First Online: 27 June 2018

Compliance with ethical standards

:

: FN is the owner of BIOAXXESS acting as PEVIVA’s/VLVbio’s distributor of M30 and M65 ELISAs in the United Kingdom and the Republic of Ireland. The remaining authors declare that they have no conflict of interest.